niacinamide and orabase

niacinamide has been researched along with orabase in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axéll, T; Birkhed, D; Björnström, M1
Abastado, JP; Chew, V; Ho, V; Kaldis, P; Lee, J; Lim, TS; Steinberg, J; Szmyd, R; Tham, M; Yaligar, J1

Trials

1 trial(s) available for niacinamide and orabase

ArticleYear
Comparison between saliva stimulants and saliva substitutes in patients with symptoms related to dry mouth. A multi-centre study.
    Swedish dental journal, 1990, Volume: 14, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ascorbic Acid; Carboxymethylcellulose Sodium; Drug Combinations; Female; Glycerol; Humans; Lactates; Lactic Acid; Middle Aged; Niacinamide; Saliva; Saliva, Artificial; Secretory Rate; Sorbitol; Xerostomia

1990

Other Studies

1 other study(ies) available for niacinamide and orabase

ArticleYear
TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression.
    Oncotarget, 2015, Sep-29, Volume: 6, Issue:29

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboxymethylcellulose Sodium; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Humans; Immune System; Immunosuppressive Agents; Liver Neoplasms; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Niacinamide; Phenylurea Compounds; Phosphorylation; Poly I-C; Polylysine; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib; Toll-Like Receptor 3

2015